- Nano Labs expands its BNB holdings by 8,000 tokens, bringing its total reserve to 128,000.
- BNB hits a new all-time high of $859.56, gaining 7.65% in the last 24 hours of trading.
- Liminatus Pharma plans a $500M BNB strategy, signaling rising institutional interest in BNB.
Nano Labs Ltd (Nasdaq: NA) has confirmed that it has substantially improved its Binance Coin (BNB) purchases, raising its total holdings to 128,000. The value of this reserve is currently over $108 million, considering the BNB market price of $850.
The latest addition includes an over-the-counter (OTC) purchase of 8,000 BNB at an average cost of $801 per token. Overall, Nano Labs’ average acquisition cost stands at $713 per BNB. It has an unrealized gain of about $137 or 19.2% per token based on the market conditions.
Nano Labs Strengthens Its Strategic Role in the BNB Ecosystem
Nano Labs stated that this acquisition aligns with its multi-layered strategy to deepen its BNB reserve portfolio. The company positions BNB as a long-term asset of its broader Web 3.0 business strategy and not just a digital reserve. Amid BNB’s recent all-time highs, the nature of Nano Labs’ state treasury of reserves demonstrates a strategic, well-timed approach to the market.
In addition to its token holdings, Nano Labs has expressed interest in building a broader investment portfolio centered around BNB. The company will target the projects and the companies that are actively operating in the BNB Chain ecosystem.
BNB Hits All-Time High Amid Broader Market Movements
According to the CoinMarketCap data, BNB hit a new all-time high of $859.56 on July 28, 2025. The milestone reflects a 7.65% rise in the last 24 hours, with BNB climbing from a low of $794.45.
The token is on an upward trend due to increased adoption and institutional entities. Simultaneously, the BNB Chain Foundation has actively supported ecosystem growth by acquisitions as part of its commitment to the $100 million incentive program.
The increased commitment to BNB is part of a greater pattern of Web 3.0 companies prioritizing the inclusion of digital assets in their capital strategies. As accumulation and ecosystem-focused investment progress, the company signals its interest in remaining active in creating the BNB enterprise activities.
Headquartered in China, Nano Labs designs high-throughput computing (HTC) and high-performance computing (HPC) chips. It has developed a unique flow processing unit (FPU) architecture and is actively building out its digital asset portfolio. In addition to holding BNB as a reserve currency, the company also holds reserves in other cryptocurrencies like Bitcoin, as part of its overall reserve diversification strategy.
Related: Nano Labs Expands to 120,000 BNB in Strategic Reserve Plan
BNB Sees Surge in Institutional Interest and Funding
Nano Labs’ strategic move coincides with broader institutional momentum in the BNB sector. On July 28, 2025, Liminatus Pharma, Inc., announced plans to launch an “American BNB Strategy” subsidiary that will target up to $500 million in BNB investments.
In addition, CEA Industries (Nasdaq: VAPE) launched a $500 million private placement to build the largest publicly listed BNB treasury vehicle. The placement is funded by more than 140 institutional investors, including Pantera Capital and Blockchain.com.
